Loading the security overview…
Where the tokens are
What BioNTech SE has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 18, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 14, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 28, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 27, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 20, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 4, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 4, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 3, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jul 30, 2026 | 20-F/A | Annual reports | On SEC.gov |
| Jul 29, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jun 8, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jun 1, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| May 22, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| May 15, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| May 7, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| May 5, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| May 5, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 13, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 2, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 1, 2026 | 20-F/A | Annual reports | On SEC.gov |
| Mar 24, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Mar 10, 2026 | 20-F | Annual report (foreign issuer) | On SEC.gov |
| Mar 10, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Mar 10, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 28, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 14, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 12, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 6, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Dec 18, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Dec 9, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Dec 8, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Dec 3, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 26, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 12, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 3, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 3, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 22, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 1, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 8, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 8, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 5, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
Figures describe BioNTech SE shares, not any token. As of Sep 30, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.